SCHEMBL2816182

SCHEMBL2816182

O=C(O)c1cccc2c1CC[C@H]2N1Cc2cccc(Cl)c2C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.46
CRBN Q96SW2 2/20 0.43
DRD2 P14416 1/20 0.42
DRD1 P21728 1/20 0.42
PARP1 P09874 7/20 0.42
POLB P06746 2/20 0.42
ESR2 Q92731 2/20 0.42
HTT P42858 1/20 0.42
CMA1 P23946 2/20 0.41
PARP2 Q9UGN5 3/20 0.41
ALOX15 P16050 1/20 0.40
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ESR1 P03372 1/20 0.38
NR4A1 P22736 1/20 0.38
APEX1 P27695 1/20 0.38
PTPN7 P35236 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2821894 1.00 MAPT (0.46) MAPTCRBNDRD2DRD1PARP1
SCHEMBL2817755 0.87 DRD2 (0.46) MAPTCRBNDRD2DRD1PARP1
SCHEMBL2817339 0.87 DRD2 (0.46) MAPTCRBNDRD2DRD1PARP1
SCHEMBL2817341 0.87 DRD2 (0.46) MAPTCRBNDRD2DRD1PARP1
SCHEMBL785746 0.83 MAPT (0.41) MAPTCRBNPARP1POLBESR2
SCHEMBL785549 0.83 MAPT (0.41) MAPTCRBNPARP1POLBESR2
SCHEMBL785795 0.81 CRBN (0.42) MAPTCRBNPARP1POLBESR2
SCHEMBL785723 0.81 CRBN (0.42) MAPTCRBNPARP1POLBESR2
SCHEMBL2816152 0.81 CRBN (0.42) MAPTCRBNPARP1POLBESR2
SCHEMBL484302 0.80 CRBN (0.42) MAPTCRBNPARP1POLBESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN MAPT 4634/4885CRBN 4520/4885DRD2 520/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN MAPT 4634/4885CRBN 4520/4885DRD2 520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.